Diallyl Trisulfide Inhibits Platelet Aggregation through the Modification of Sulfhydryl Groups
Diallyl Trisulfide Inhibits Platelet Aggregation through the Modification of Sulfhydryl Groups
复制标题
二烯丙基三硫化物通过巯基修饰抑制血小板聚集
DOI:
10.1021/acs.jafc.9b05557
复制
发表时间:
2020
影响因子:
6.1
通讯作者:
Taiichiro Seki
中科院分区:
文献类型:
--
作者:
Takashi Hosono;Asuka Sato;Natsumi Nakaguchi;Yori Ozaki-Masuzawa;Taiichiro Seki
Diallyl trisulfide (DATS) is a secondary metabolite of allicin, a volatile organosulfur flavoring compound generated by the crushing of garlic. These compounds have various medicinal effects such as antiplatelet activity. In this study, we demonstrated for the first time the cellular mechanism involved in the inhibition of platelet aggregation by DATS and dipropyl trisulfide (DPTS), which is a saturated analogue of DATS. Washed murine platelets were incubated with these sulfides, and platelet aggregation was evaluated by light transmission aggregometry. The amount of reaction products produced by DATS, DPTS, and glutathione (GSH) was measured using liquid chromatography–mass spectrometry. Compared with DPTS, DATS potently inhibited platelet aggregation induced by thrombin, U46619, and collagen.N-Ethylmaleimide (NEM), which is commonly used to modify sulfhydryl groups, also suppressed platelet aggregation. The reactivity of DATS with GSH was higher than that of DPTS. These data suggested that DATS inhibited platelet aggregation through the reaction of sulfhydryl groups.